PrednisoneAdrenal Cortex HormonesGlucocorticoidsPrednisoloneVincristineAnti-Inflammatory AgentsAdministration, InhalationMethylprednisoloneCyclophosphamideImmunosuppressive AgentsTreatment OutcomeBeclomethasoneAsthmaDrug Therapy, CombinationAzathioprineAnti-Asthmatic AgentsBudesonideDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsProcarbazineDrug Administration ScheduleDexamethasoneTriamcinoloneMechlorethamineBetamethasonePregnenedionesAdministration, TopicalHydrocortisoneAdministration, OralMelphalanAntibodies, Monoclonal, Murine-DerivedFluocinolone AcetonideBronchodilator AgentsCyclosporineMethylprednisolone HemisuccinateMethotrexateMitoxantroneMycophenolic AcidFollow-Up StudiesRemission InductionDouble-Blind MethodAndrostadienesTriamcinolone AcetonideTime FactorsBleomycinCortisoneTacrolimusChlorambucilPolymyalgia RheumaticaInjections, Intra-ArticularRecurrenceRetrospective StudiesColor TherapyLymphoma, Non-HodgkinDose-Response Relationship, DrugKidney TransplantationProspective StudiesForced Expiratory VolumeGraft RejectionSarcoidosisPulse Therapy, DrugHodgkin DiseaseNephrotic SyndromePregnadienediolsLymphoma, Large B-Cell, DiffuseAlbuterolVinblastineSteroidsSeverity of Illness IndexArthritis, RheumatoidThalidomideMultiple MyelomaSurvival AnalysisGiant Cell ArteritisScleritisReceptors, MineralocorticoidPeak Expiratory Flow RateAsparaginaseCombined Modality TherapyClinical Trials as TopicTranscortinLupus Erythematosus, SystemicSurvival RateClobetasolEtoposideAdrenocortical HyperfunctionDisease-Free SurvivalAdrenal InsufficiencyImmunosuppressionAcute DiseaseAntirheumatic AgentsCorticosteroneLeukotriene AntagonistsPrognosisPulmonary Disease, Chronic ObstructiveAdrenergic beta-AgonistsBiopsyEosinophiliaNebulizers and VaporizersChronic Disease